Meritage Portfolio Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-29,397
| Closed | -$22.2M | – | 338 |
|
|
2021
Q4 | $22.2M | Sell |
29,397
-412
| -1% | -$311K | 1.26% | 16 |
|
|
2021
Q3 | $22.2M | Buy |
29,809
+34
| +0.1% | +$25.4K | 1.33% | 13 |
|
|
2021
Q2 | $19.2M | Sell |
29,775
-311
| -1% | -$200K | 1.16% | 17 |
|
|
2021
Q1 | $17.2M | Sell |
30,086
-1,231
| -4% | -$703K | 1.15% | 19 |
|
|
2020
Q4 | $18.3M | Buy |
31,317
+133
| +0.4% | +$77.5K | 1.34% | 16 |
|
|
2020
Q3 | $16.1M | Sell |
31,184
-104
| -0.3% | -$53.6K | 1.44% | 15 |
|
|
2020
Q2 | $14.1M | Buy |
31,288
+1,204
| +4% | +$544K | 1.36% | 19 |
|
|
2020
Q1 | $10.5M | Buy |
+30,084
| New | +$10.5M | 1.43% | 17 |
|